News

2026.02.12
Genomtec lines up technology trials with potential Asian partners during M&A efforts

2025.07.31
Genomtec's Supervisory Board appointed Leroy Huntley to the Company's Management Board

2025.07.14
Genomtec has the consent of its shareholders to make a contribution of assets to its subsidiaries in order to accelerate the project sale process

2025.03.26
Genomtec implements changes in organizational structure to accelerate M&A process

2025.03.12
The company will obtain approximately PLN 11 million from the issue to support the commercialization of projects

Archive

2022.06.08

Genomtec®ID Respiratory Panel 5-Plex (RP5-PLEX) for the detection of respiratory tract infections has received CE-IVD certification as the only solution of its kind in Europe

Genomtec has obtained the CE-IVD mark for its flagship solution, the Genomtec®ID Respiratory Panel 5-Plex (RP5-PLEX) diagnostic panel for the ...
Read
2022.04.29

Genomtec signs distribution agreement for Genomtec®ID in Europe

Genomtec has signed an exclusive distribution agreement in Greece for its flagship Genomtec®ID genetic testing platform and the Respiratory Panel ...
Read
2022.02.14

Genomtec begins comparative testing phase of Genomtec®ID

Genomtec has started the comparative testing phase of Genomtec®ID, a mobile platform for genetic diagnostics and the Respiratory Panel (RP) ...
Read
2022.01.20

European Patent Office grants Genomtec with new Patent

Genomtec has received a patent from the European Patent Organization (EPO) for the Genomtec®ID technology and device invented by Genomtec SA.  ...
Read
2022.01.12

Genomtec begins pilot production of Genomtec®ID analyzers

Genomtec has conducted an analysis of its rapid genetic tests that confirmed their effectiveness in detecting all known variants of the ...
Read
2021.12.31

Change of address of Genomtec office in Wroclaw

Genomtec has conducted an analysis of its rapid genetic tests that confirmed their effectiveness in detecting all known variants of the ...
Read

Archive